VMDViemed Healthcare, Inc.

$9.79+43% 1Y

$9.79

$6.2652 weeks$12.35

Is the price fair?

Fair

Neither cheap nor expensive: nothing decisive, though modest expectations priced in.

1 good, 1 neutral, 1 without data

What the price assumes~−0% a yearderived · Jun 30, 2026

Priced for a decline (~−0% a year). The price demands less than its three-year revenue growth of 25% a year, expectations look modest.

Vs its own P/E rangemid-range for this companyderived

In its normal range: P/E 27.2 vs a 26.7 median over 28 quarters (+2% vs median).

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

Viemed Healthcare, Inc. trades at 27.2× earnings against 28.1× for the median Medical Devices name, cheaper than its own group.

27.2

Trailing P/E · Medical Devices median 28.1 · cheaper than the typical name in its group

Price / sales: 1.55
Price / sales · as of 2026-Q2
Free cash flow yield: 7.8%
Free cash flow yield · Medical Devices median 4.0%
Growth the price implies: −0.34%
Growth the price implies · The price pays for −0.34% free cash flow growth a year for a decade; the business has delivered +38% a year over the last three.

Details›

What the market has paid for these earnings: 28 quarters of its own multiple × $0.36 of trailing earnings per share
Method	Per share
Its own P/E history, lower quartile	$7.22
Its own P/E history, median	$9.61
Its own P/E history, upper quartile	$11.31
52-week range	$6.26 – $12.35
Today	$9.79

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.